Alnylam Pharmaceuticals, Inc. (ALNY)
332.92
+1.68
(+0.51%)
USD |
NASDAQ |
Feb 27, 16:00
332.74
-0.18
(-0.05%)
After-Hours: 20:00
Alnylam Pharmaceuticals Total Liabilities (Quarterly) : 4.236B for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Insmed, Inc. | 1.526B |
| Biogen, Inc. | 11.18B |
| Pfizer Inc. | 121.38B |
| Eli Lilly & Co. | 85.94B |
| AbbVie, Inc. | 137.19B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.026B |
| Shareholders Equity (Quarterly) | 789.18M |
| Debt to Equity Ratio | 3.762 |
| Current Ratio | 2.762 |
| Net Debt Paydown Yield | -0.09% |